EARNEST Partners’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-651
| Closed | -$34.4K | – | 403 |
|
2023
Q3 | $34.4K | Hold |
651
| – | – | ﹤0.01% | 408 |
|
2023
Q2 | $35.2K | Hold |
651
| – | – | ﹤0.01% | 386 |
|
2023
Q1 | $32.6K | Hold |
651
| – | – | ﹤0.01% | 389 |
|
2022
Q4 | $30.1K | Hold |
651
| – | – | ﹤0.01% | 404 |
|
2022
Q3 | $25K | Hold |
651
| – | – | ﹤0.01% | 408 |
|
2022
Q2 | $24K | Hold |
651
| – | – | ﹤0.01% | 421 |
|
2022
Q1 | $29K | Hold |
651
| – | – | ﹤0.01% | 411 |
|
2021
Q4 | $28K | Hold |
651
| – | – | ﹤0.01% | 431 |
|
2021
Q3 | $28K | Hold |
651
| – | – | ﹤0.01% | 414 |
|
2021
Q2 | $28K | Hold |
651
| – | – | ﹤0.01% | 413 |
|
2021
Q1 | $25K | Hold |
651
| – | – | ﹤0.01% | 417 |
|
2020
Q4 | $23K | Hold |
651
| – | – | ﹤0.01% | 417 |
|
2020
Q3 | $25K | Hold |
651
| – | – | ﹤0.01% | 372 |
|
2020
Q2 | $23K | Hold |
651
| – | – | ﹤0.01% | 374 |
|
2020
Q1 | $21K | Hold |
651
| – | – | ﹤0.01% | 368 |
|
2019
Q4 | $29K | Hold |
651
| – | – | ﹤0.01% | 380 |
|
2019
Q3 | $26K | Hold |
651
| – | – | ﹤0.01% | 389 |
|
2019
Q2 | $28K | Hold |
651
| – | – | ﹤0.01% | 384 |
|
2019
Q1 | $25K | Hold |
651
| – | – | ﹤0.01% | 401 |
|
2018
Q4 | $23K | Hold |
651
| – | – | ﹤0.01% | 397 |
|
2018
Q3 | $25K | Hold |
651
| – | – | ﹤0.01% | 397 |
|
2018
Q2 | $21K | Hold |
651
| – | – | ﹤0.01% | 421 |
|
2018
Q1 | $18K | Hold |
651
| – | – | ﹤0.01% | 441 |
|
2017
Q4 | $16K | Buy |
+651
| New | +$16K | ﹤0.01% | 456 |
|
2017
Q1 | – | Sell |
-651
| Closed | -$14K | – | 341 |
|
2016
Q4 | $14K | Buy |
+651
| New | +$14K | ﹤0.01% | 456 |
|